Gary Charles Robb, Chief Financial Officer at CORCEPT THERAPEUTICS INC (CORT), sold 115,500 shares at $29.78 ($3.3M) on 2021-02-11, disclosed to the SEC on 2021-02-16.
Open-market sale of $3.3M CORT by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.78 | 3,400 | $101K | 3.1% |
| 2 | $28.22 | 112,100 | $3.2M | 96.9% |
| Total | $28.27 avg | 115,500 | $3.3M | 100% |
| Filing → |
| CORT | SELL | 2025-06-18 | $451K | — | Filing → |
| CORT | SELL | 2025-05-22 | $346K | — | Filing → |
| CORT | SELL | 2025-01-06 | $556K | — | Filing → |